Stock listing
Frankfurt:9T7 Eden Research plc Aktie
German listing (Frankfurt) of Eden Research plc · home listing LSE:EDEN
Follow Eden Research plc into a list and get an email when it puts out news.
Share price · FWB:9T7
€0.033 EUR 0.000 (0.0%)
Close on Nov 20, 2026
- Day range
- €0.023 – €0.033 EURNov 20, 2026
- Market cap
- €29.54M EURAt the close on Nov 20, 2026 · price × 908.8M shares outstanding
- 52-week range
- €0.015 – €0.049 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €5 EURMedian day 0 shares · 56 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:EDEN · Home | 3.10p GBX (pence) | +0.10 (+3.3%) | 216,998 | 3.10p | 3.20p | 3.03p | 3.00p | Close on Nov 20, 2026 |
| Frankfurt:9T7 | €0.033 EUR | 0.000 (0.0%) | — | €0.023 | €0.033 | €0.023 | €0.033 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:9T7 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.033 | -0.001 | -2.9% | €0.024 | €0.033 | €0.024 | 0 | |
| €0.034 | 0.000 | 0.0% | €0.024 | €0.034 | €0.024 | 0 | |
| €0.034 | -0.002 | -5.6% | €0.026 | €0.035 | €0.026 | 0 | |
| €0.036 | -0.004 | -10.0% | €0.029 | €0.042 | €0.029 | 0 | |
| €0.040 | +0.006 | +17.6% | €0.024 | €0.040 | €0.024 | 0 | |
| €0.034 | +0.004 | +13.3% | €0.022 | €0.034 | €0.022 | 0 | |
| €0.030 | 0.000 | 0.0% | €0.021 | €0.030 | €0.021 | 0 | |
| €0.030 | +0.002 | +7.1% | €0.021 | €0.031 | €0.021 | 0 | |
| €0.028 | +0.004 | +16.7% | €0.019 | €0.028 | €0.018 | 0 | |
| €0.024 | 0.000 | 0.0% | €0.018 | €0.024 | €0.018 | 0 | |
| €0.024 | 0.000 | 0.0% | €0.019 | €0.024 | €0.018 | 0 | |
| €0.024 | 0.000 | 0.0% | €0.018 | €0.024 | €0.018 | 0 | |
| €0.024 | 0.000 | 0.0% | €0.019 | €0.024 | €0.019 | 0 | |
| €0.024 | 0.000 | 0.0% | €0.018 | €0.024 | €0.018 | 0 | |
| €0.024 | +0.001 | +4.3% | €0.018 | €0.024 | €0.018 | 0 | |
| €0.023 | 0.000 | 0.0% | €0.018 | €0.024 | €0.018 | 0 | |
| €0.023 | 0.000 | 0.0% | €0.018 | €0.023 | €0.018 | 0 | |
| €0.023 | 0.000 | 0.0% | €0.018 | €0.023 | €0.018 | 0 | |
| €0.023 | 0.000 | 0.0% | €0.018 | €0.023 | €0.017 | 0 | |
| €0.023 | 0.000 | 0.0% | €0.018 | €0.023 | €0.018 | 0 | |
| €0.023 | -0.001 | -4.2% | €0.018 | €0.024 | €0.017 | 0 | |
| €0.024 | 0.000 | 0.0% | €0.017 | €0.024 | €0.017 | 0 | |
| €0.024 | 0.000 | 0.0% | €0.017 | €0.024 | €0.017 | 0 | |
| €0.024 | 0.000 | 0.0% | €0.017 | €0.024 | €0.017 | 0 | |
| €0.024 | 0.000 | 0.0% | €0.017 | €0.024 | €0.017 | 0 | |
| €0.024 | +0.002 | +9.1% | €0.016 | €0.024 | €0.016 | 0 | |
| €0.022 | -0.001 | -4.3% | €0.017 | €0.022 | €0.017 | 0 | |
| €0.023 | +0.003 | +15.0% | €0.016 | €0.023 | €0.016 | 0 | |
| €0.020 | 0.000 | 0.0% | €0.016 | €0.020 | €0.016 | 0 | |
| €0.020 | +0.001 | +5.3% | €0.016 | €0.021 | €0.016 | 0 | |
| €0.019 | 0.000 | 0.0% | €0.016 | €0.019 | €0.016 | 0 | |
| €0.019 | 0.000 | 0.0% | €0.016 | €0.020 | €0.015 | 0 | |
| €0.019 | 0.000 | 0.0% | €0.016 | €0.020 | €0.016 | 0 | |
| €0.019 | -0.001 | -5.0% | €0.016 | €0.020 | €0.015 | 0 | |
| €0.020 | +0.001 | +5.3% | €0.016 | €0.020 | €0.015 | 0 | |
| €0.019 | 0.000 | 0.0% | €0.015 | €0.019 | €0.015 | 0 | |
| €0.019 | 0.000 | 0.0% | €0.016 | €0.019 | €0.016 | 0 | |
| €0.019 | -0.002 | -9.5% | €0.015 | €0.021 | €0.015 | 0 | |
| €0.021 | 0.000 | 0.0% | €0.017 | €0.021 | €0.016 | 0 | |
| €0.021 | +0.001 | +5.0% | €0.016 | €0.021 | €0.016 | 0 | |
| €0.020 | 0.000 | 0.0% | €0.016 | €0.021 | €0.016 | 0 | |
| €0.020 | 0.000 | 0.0% | €0.016 | €0.021 | €0.016 | 0 | |
| €0.020 | -0.001 | -4.8% | €0.016 | €0.020 | €0.016 | 0 | |
| €0.021 | +0.001 | +5.0% | €0.016 | €0.021 | €0.016 | 0 | |
| €0.020 | -0.001 | -4.8% | €0.016 | €0.020 | €0.016 | 0 | |
| €0.021 | +0.001 | +5.0% | €0.016 | €0.021 | €0.016 | 0 | |
| €0.020 | -0.001 | -4.8% | €0.016 | €0.020 | €0.016 | 0 | |
| €0.021 | 0.000 | 0.0% | €0.016 | €0.021 | €0.016 | 0 | |
| €0.021 | +0.005 | +31.3% | €0.017 | €0.021 | €0.017 | 0 | |
| €0.016 | -0.005 | -23.8% | €0.016 | €0.028 | €0.016 | 18,000 | |
| €0.021 | 0.000 | 0.0% | €0.017 | €0.021 | €0.017 | 0 | |
| €0.021 | 0.000 | 0.0% | €0.017 | €0.021 | €0.016 | 0 | |
| €0.021 | -0.002 | -8.7% | €0.017 | €0.022 | €0.017 | 0 | |
| €0.023 | 0.000 | 0.0% | €0.017 | €0.023 | €0.017 | 0 | |
| €0.023 | 0.000 | 0.0% | €0.017 | €0.023 | €0.017 | 0 | |
| €0.023 | 0.000 | 0.0% | €0.017 | €0.023 | €0.017 | 0 | |
| €0.023 | 0.000 | 0.0% | €0.017 | €0.023 | €0.017 | 0 |
- Ticker
- Frankfurt:9T7
- Asset type
- Stock
- Sector
- Chemicals & materials
- Industry
- Fertilizers & crop chemicals
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 17, 2026
Ecovelex 2026 Approval in Italy
Latest earnings call · Aug 26, 2026
Eden Research (LSE:EDEN) — Preliminary results for the fifteen months ended 31 March 2026
Replay and transcript
Latest deck · Sep 29, 2026
Shareholder Meeting (September 2026)
Shareholder meeting · 27 slides
Latest news
Attendance at Annual Biocontrol Industry meeting
Oct 19, 2026
Closed €0.024 (+4.3%) on Oct 19, 2026
Investor presentation
Oct 6, 2026
Closed €0.024 (0.0%) on Oct 6, 2026
Change of Name
Oct 1, 2026
Closed €0.022 (-4.3%) on Oct 1, 2026
US EPA approves expanded label for Mevalone
Sep 28, 2026
Closed €0.02 (+5.3%) on Sep 28, 2026
Grant of Awards under LTIP PDMR Dealing
Sep 17, 2026
Closed €0.019 (0.0%) on Sep 17, 2026
Regulatory approvals in Slovakia and Egypt
Aug 4, 2026
Closed €0.026 (+4.0%) on Aug 4, 2026
2026 Green Economy Mark
Jun 25, 2026
Closed €0.03 (0.0%) on Jun 25, 2026
Directorate change
May 27, 2026
Closed €0.034 (0.0%) on May 27, 2026
Eden Research plc on 6ix
- Sector
- Chemicals & materials
- Industry
- Fertilizers & crop chemicals
- News releases
- 20 in the last 12 months · 218 in all · newest Nov 17, 2026 · oldest 2012
- Calls
- 7 calls with a replay · 7 with a transcript · latest Aug 26, 2026
- Decks
- 26 decks · latest Sep 29, 2026
Where Eden Research plc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:EDEN · Home listing | LSE | United Kingdom | GBX |
| OTC:EDNSF | OTC | United States | USD |
| Stuttgart:9T7 | Stuttgart | Germany | EUR |
| AQUIS:EDEN.GB | AQUIS | United Kingdom | GBX |
| Frankfurt:9T7 · This page | Frankfurt | Germany | EUR |
Valuation
Price/book 2.4× against a median of 1.3×: 7th lowest of 9 Fertilizers & crop chemicals companies shown. balance Jun 30, 2025 · price Nov 20, 2026
- Enterprise value
- £23.63M GBP
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 2.4×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Fertilizers & crop chemicals: the 10 companies nearest in size, of 113 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Eden Research plc · LSE:EDEN | US$32.61M | US$30.94M | n/a | n/a | n/a | 2.4× | n/a | 0.1× | n/a |
| Khaitan Chemicals & Fertilizers Ltd. · NSE:KHAICHEM | US$49.30M | US$49.30M | 8.4× | 0.5× | 4.4× | 1.6× | 5.5% | 0.0× | n/a |
| Rama Phosphates Limited · NSE:RAMAPHO | US$45.71M | US$45.71M | 7.9× | 0.5× | 4.8× | 1.0× | 5.8% | 0.0× | n/a |
| Amoeba SA · EURONEXT:ALMIB | US$36.86M | US$45.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Chobi Co., Ltd. · KRX:001550 | US$34.61M | US$31.93M | 18.2× | 0.4× | 6.0× | 0.8× | 2.2% | 0.0× | n/a |
| SBSUNGBO Co., Ltd. · KRX:003080 | US$31.08M | US$14.63M | n/a | 0.3× | n/a | 0.3× | −20.8% | 0.0× | n/a |
| Pato Chemical Industries Public Co. Ltd. · SET:PATO | US$25.24M | US$21.26M | 14.5× | 1.6× | 9.8× | 1.9× | 13.3% | 0.0× | n/a |
| Sikko Industries Ltd. · NSE:SIKKO | US$24.84M | US$25.55M | 35.8× | 3.5× | 27.9× | 2.5× | 9.4% | 0.1× | n/a |
| Replenish Nutrients Holding Corp. · CSE:ERTH | US$24.03M | US$24.13M | n/a | 5.5× | n/a | 6.3× | −150.4% | 0.1× | 0.07 |
| Fertilizantes Heringer S.A. · BMFBOVESPA:FHER3 | US$23.07M | US$103.8M | n/a | 0.2× | n/a | n/a | −6.8% | n/a | n/a |
| Nova Agritech Limited · NSE:NOVAAGRI | US$21.64M | US$21.64M | 15.6× | 0.7× | 5.5× | 0.9× | 4.7% | 0.0× | n/a |
| Median of the others | US$28.16M | US$28.74M | 15.0× | 0.5× | 5.8× | 1.3× | 4.7% | 0.0× | 0.07 |
Forecasts
Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 20.00 GBX · Analysts' mean
- EPS, year to Mar 2027
- -0.003 · 1 analyst
- Revenue, year to Mar 2027
- 6.1M · 1 analyst
Events
| Call | When | Status |
|---|---|---|
| Eden Research (LSE:EDEN) — Preliminary results for the fifteen months ended 31 March 2026 | Wed, Aug 26, 2026 · 5:00 AM ET | Replay |
| Eden Research (LSE:EDEN) — Interim Results | Wed, Sep 17, 2025 · 6:00 AM ET | Replay |
| Eden Research (LSE:EDEN) — Preliminary results for the year ended 31 December 2024 | Wed, May 14, 2025 · 9:00 AM ET | Replay |
| Eden Research (LSE:EDEN) — Investor Update - February 2025 | Thu, Feb 13, 2025 · 6:00 AM ET | Replay |
| Eden Research (LSE:EDEN) — Interim Results | Mon, Sep 23, 2024 · 9:00 AM ET | Replay |
| Eden Research (LSE:EDEN) — Investor Presentation | Thu, May 16, 2024 · 10:00 AM ET | Replay |
| Eden Research (LSE:EDEN) — Full Year Results | Thu, Jun 09, 2022 · 5:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (September 2026) | Shareholder meeting | 27 slides | Sep 29, 2026 |
| 15 months to 31 March 2026 Earnings Presentation | Earnings | 25 slides | August 2026 |
| H1 2025 Earnings Presentation | Earnings | 19 slides | Sep 17, 2025 |
| Shareholder Meeting (June 2025) | Shareholder meeting | 16 slides | Jun 18, 2025 |
| FY2024 Earnings Presentation | Earnings | 15 slides | May 2025 |
| Investor Presentation (February 2025) | Investor deck | 13 slides | Feb 13, 2025 |
| H1 2024 Earnings Presentation | Earnings | 30 slides | Sep 23, 2024 |
| Shareholder Meeting (June 2024) | Shareholder meeting | 44 slides | Jun 27, 2024 |
| FY2023 Earnings Presentation | Earnings | 33 slides | May 2024 |
| ShareSoc Growth Company Seminar 2024 | Conference | 30 slides | Feb 28, 2024 |
All 26 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (June 2023) | Shareholder meeting | 37 slides | Jun 29, 2023 |
| FY2022 Earnings Presentation | Earnings | 29 slides | May 2023 |
| Master Investor Show 2023 | Conference | 23 slides | Apr 15, 2023 |
| FY2022 Earnings Presentation | Earnings | 29 slides | March 2023 |
| Shareholder Meeting (June 2022) | Shareholder meeting | 35 slides | Jun 29, 2022 |
| FY2021 Earnings Presentation | Earnings | 28 slides | Jun 7, 2022 |
| ESG Presentation (April 2022) | Sustainability | 13 slides | April 2022 |
| Fact Sheet (July 2021) | Fact sheet | 2 slides | July 2021 |
| Investor Presentation (June 2021) | Investor deck | 29 slides | Jun 30, 2021 |
| H1 2020 Earnings Presentation | Earnings | 32 slides | Sep 30, 2020 |
| Fact Sheet (2020) | Fact sheet | 2 slides | May 28, 2020 |
| Proactive Investors One2One Forum (February 2019) | Conference | 29 slides | February 2019 |
| H1 2017 Earnings Presentation | Earnings | 19 slides | Sep 29, 2017 |
| Shareholder Meeting (2016) | Shareholder meeting | 24 slides | 2016 |
| Shareholder Meeting (June 2015) | Shareholder meeting | 13 slides | Jun 10, 2015 |
| Investor Presentation (2015) | Investor deck | 21 slides | 2015 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of new ordinary shares Closed: Cavendish Capital Markets Limited +1 Dealers: Cavendish Capital Markets Limited (co-lead), Oberon Investments Limited (co-lead) Use of proceeds: Insecticide formulation and Late Blight fungicide; conditional placing for Septoria wheat fungicide and commercial and operational scale up | Apr 10, 2026 | |
| Retail Offer Shares (new ordinary shares) Closed: £200,000 raised · GBX 4 a share · Oberon Investments Limited +1 Dealers: Oberon Investments Limited (co-lead), Cavendish Capital Markets Limited Use of proceeds: Develop, register and commercialise Eden's insecticide formulation and develop a new fungicide for Late Blight in potatoes | Feb 5, 2026 | US$271,044 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in GBP
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.30M | 3.19M | 1.83M | 1.23M | 1.37M | 1.83M | 2.77M | 1.88M | 392.0K | 883.3K |
| Cost of revenue | 2.43M | 1.43M | 1.62M | 1.20M | 1.36M | 963.7K | 1.24M | 1.02M | 28.6K | 98.7K |
| Gross profit | 1.87M | 1.77M | 207.1K | 28.3K | 9.63K | 861.8K | 1.54M | 857.9K | 363.4K | 784.6K |
| Research and development | 298.1K | 291.4K | 348.4K | 225.9K | 315.2K | 231.1K | 183.0K | 290.3K | 225.1K | 200.1K |
| Selling, general and administrative | 3.51M | 3.00M | 2.75M | 2.69M | 2.20M | 2.03M | 1.52M | 1.43M | 1.44M | 1.27M |
| Operating income | -2.19M | -1.87M | -2.57M | -3.21M | -2.24M | -1.36M | -497.0K | -1.35M | -1.89M | -1.14M |
| Depreciation and amortization | 583.2K | 625.1K | 687.4K | 590.0K | 622.8K | 518.8K | 429.9K | 750.2K | 680.3K | 455.2K |
| EBITDA | -1.60M | -1.24M | -1.88M | -2.62M | -1.62M | -838.8K | -67.2K | -601.1K | -1.21M | -683.4K |
| Interest expense | 10.6K | 17.2K | 22.0K | 32.1K | 24.0K | 8.40K | 551 | 1.24K | 484 | 422 |
| Income before tax | -2.18M | -6.92M | -2.57M | -3.40M | -2.55M | -1.44M | -533.1K | -762.9K | -1.91M | -1.26M |
| Income tax | -267.0K | -428.3K | -323.7K | -618.1K | -285.1K | -347.0K | -198.1K | -123.8K | -81.9K | -101.3K |
| Net income | -1.91M | -6.49M | -2.24M | -2.79M | -2.27M | -1.14M | -335.0K | -639.1K | -1.83M | -1.16M |
| Earnings per share, basic | -0.00 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.01 | -0.01 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.67M | 7.41M | 1.99M | 3.83M | 7.29M | 502.0K | 2.48M | 3.68M | 1.53M | 148.4K |
| Short-term investments | 2.48M | 3.68M | ||||||||
| Receivables | 2.86M | 2.06M | 479.7K | 759.9K | 1.15M | 1.59M | 515.3K | 732.0K | 240.5K | 164.4K |
| Inventory | 532.6K | 964.6K | 625.5K | 521.4K | 224.4K | 68.4K | 14.7K | 206.8K | 1 | |
| Current assets | 7.90M | 11.1M | 3.60M | 6.14M | 9.19M | 2.47M | 3.41M | 4.85M | 1.77M | 312.8K |
| Property, plant and equipment | 605.1K | 582.7K | 61.8K | |||||||
| Total assets | 15.4M | 16.6M | 12.9M | 15.0M | 16.9M | 8.86M | 9.22M | 10.6M | 7.80M | 6.68M |
| Accounts payable | 2.56M | 1.93M | 1.15M | 1.15M | 794.4K | 870.6K | 499.2K | 1.56M | 120.8K | 326.9K |
| Current liabilities | 3.51M | 2.96M | 1.95M | 1.81M | 1.54M | 1.37M | 875.4K | 2.00M | 965.3K | 752.6K |
| Total debt | 168.7K | 229.8K | 355.3K | 398.4K | 415.2K | 69.5K | ||||
| Total liabilities | 3.57M | 3.05M | 2.17M | 2.20M | 2.00M | 1.52M | 942.9K | 2.07M | 1.03M | 752.6K |
| Shareholders' equity | 11.8M | 13.5M | 10.7M | 12.8M | 14.9M | 7.34M | 8.28M | 8.51M | 6.76M | 5.93M |
| Shares outstanding | 533.4M | 420.9M | 380.5M | 380.3M | 344.6M | 208.6M | 208.2M | 195.7M | 178.4M | 155.7M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.01M | -1.70M | -683.1K | -1.62M | -1.02M | -1.01M | -701.7K | 230.0K | -805.8K | -104.9K |
| Capital spending | -2.59M | -102.4K | -1.05M | -1.73M | -1.90M | -913.9K | -512.6K | -472.1K | -238.0K | -132.0K |
| Free cash flow | -3.60M | -1.80M | -1.74M | -3.34M | -2.92M | -1.93M | -1.21M | -242.0K | -1.04M | -236.9K |
| Cash from investing | -2.48M | -1.72M | -1.05M | -1.73M | -1.90M | -913.9K | -510.9K | -446.6K | -347.9K | -131.8K |
| Cash from financing | -155.5K | 8.90M | -150.3K | -90.4K | 9.71M | -20.9K | 13.0K | 2.36M | 2.54M | -30.0K |
| Share buybacks | 2.40M | 2.67M | 2.67M | |||||||
| Change in cash | -3.74M | 5.42M | -1.83M | -3.46M | 6.78M | -1.98M | -1.20M | 2.15M | 1.38M | -266.6K |
Cap table
Built by 6ix from Eden Research plc’s releases · as of Apr 10, 2026
- Common shares
- 803,362,994
- Fully diluted
- 803,362,994
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 803,362,994 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 803,362,994 |
Log in to ask 6ix AI your own questions about Eden Research plc.